M R Shalaby - Concepedia

Author

M R Shalaby

Also Known As

M R Shalaby, M Refaat Shalaby, M Shalaby, M. R. Shalaby, M. REFAAT SHALABY, M. Refaat Shalaby, M.R. Shalaby, M.Refaat Shalaby, Maha Shalaby, Mohsen Shalaby

Publications

5.5K

Citations

H-Index

Concepts

All Affiliations

University of California, San Francisco Neurological Surgery California Pacific Medical Center Sunesis (United States)PDL BioPharma (United States)

About

M R Shalaby is an author at University of California, San Francisco specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	24	3.9K
2	Allergy	5	5	391
3	Engineering	1	1	1.1K
4	Public Health	1	1	254
5	Biomolecular Engineering	1	1	39

M R Shalaby

Publications

5.4K

Citations

H-Index

Page 1

	Year	Citations
Antibody Targeting of Long-Circulating Lipidic Nanoparticles Does Not Increase Tumor Localization but Does Increase Internalization in Animal Models Dmitri B. Kirpotin, Daryl C. Drummond, Yi Shao, Cancer Research NanoparticlesDoes Increase InternalizationIncrease Tumor LocalizationEngineeringBreast Oncology	2006	1.1K
Activation of human polymorphonuclear neutrophil functions by interferon-<i>gamma</i> and tumor necrosis factors. M R Shalaby, B B Aggarwal, Emily Rinderknecht, The Journal of Immunology	1985	913
Inhibition of cytokine production by cyclosporin A and transforming growth factor beta. Terje Espevik, Irene S. Figari, M R Shalaby, The Journal of Experimental Medicine ImmunologyCyclosporin AImmunologic MechanismCell ProliferationImmunotherapy	1987	454
Endotoxin, tumor necrosis factor-α and interleukin 1 induce interleukin 6 production in vivo M R Shalaby, Anders Waage, L Aarden, Clinical Immunology and Immunopathology InflammationInduce Interleukin 6CytokineImmune Cell DevelopmentImmunology	1989	295
Tumor Antigen and Human Chorionic Gonadotropin in CaSki Cells: A New Epidermoid Cervical Cancer Cell Line Roland A. Pattillo, Robert O. Hussa, Michael T. Story, Science Human Chorionic GonadotropinImmunologyPathologyGynecologyCell Culture	1977	254
Receptor Binding and Activation of Polymorphonuclear Neutrophils by Tumor Necrosis Factor-Alpha M R Shalaby, Michael A. Palladino, Sue E. Hirabayashi, Journal of Leukocyte Biology Rtnf-alpha-activated PmnsImmunologyCell DeathPathologyPmn Production	1987	216
Characterization of the antitumor activities of human tumor necrosis factor-<i>alpha</i> and the comparison with other cytokines: induction of tumor-specific immunity. Michael A. Palladino, M R Shalaby, Susan M. Kramer, The Journal of Immunology	1987	200
Development of humanized bispecific antibodies reactive with cytotoxic lymphocytes and tumor cells overexpressing the HER2 protooncogene. M R Shalaby, H. Michael Shepard, Leonard G. Presta, The Journal of Experimental Medicine Bispecific FImmunocytochemical TechniqueHer2 ProtooncogeneBispecific AntibodyImmunology	1992	176
Therapeutic efficacy of anti-ErbB2 immunoliposomes targeted by a phage antibody selected for cellular endocytosis Ulrik B. Nielsen, Dmitri B. Kirpotin, Edward M. Pickering, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ImmunologyEndocytic PathwayExtracellular MicrovesiclesCellular EndocytosisIntracellular Trafficking	2002	175
Cytokine regulation of interleukin 6 production by human endothelial cells M R Shalaby, Anders Waage, Terje Espevik Cellular Immunology InflammationEndothelial Cell PathobiologyCytokineAutoimmune DiseaseCytokine Regulation	1989	170

Page 1